Jerrold D. Dotson's most recent trade in VistaGen Therapeutics Inc was a trade of 167 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on June 30, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 3,671 (0%) | 0% | 1.6 | 265 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.09 per share. | 30 Dec 2022 | 5,000 | 105,111 (0%) | 0% | 0.1 | 438 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 30 Jun 2022 | 5,000 | 100,111 (0%) | 0% | 0.7 | 3,740 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 18,750 | 15,625 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 11 Jan 2022 | 18,750 | 94,571 (0%) | 0% | 1 | 18,750 | Common Stock |